Skip to content

Omeros OMER Interest Paid

Interest Paid at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
$1.75M+600%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$20.83M+15.1%
Vera Therapeutics logo
Vera TherapeuticsVERA
$1.63M+3.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$65K-15.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$465.75M-2.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$3.58M+51.0%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's interest paid?
Omeros (OMER) reported interest paid of $5.57M in Q1 2026.
How has Omeros's interest paid changed year-over-year?
Omeros's interest paid decreased by 45.5% year-over-year, from $10.22M to $5.57M.
What is the long-term trend for Omeros's interest paid?
Over 4 years (2021 to 2025), Omeros's interest paid has grown at a 18.6% compound annual growth rate (CAGR), from $17.88M to $35.42M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.